Book a demo

Company intelligence

Quant Bio Res A/S

Innovative Peptide Solutions for a Healthier Tomorrow

Biotechnology Research
Founded 2020
1 public signals

About Quant Bio Res A/S

QBR A/S is a Danish biotech company pioneering the development of novel antimicrobial and antiviral peptides as a new class of therapeutics for infectious diseases. At the intersection of physics and chemistry, QBR leverages the groundbreaking Resonant Recognition Model (RRM) to revolutionize drug design. In addition to its core applications in microbial and viral defense, the RRM model has shown remarkable effectiveness when applied to light optimization—enhancing photosynthesis and accelerating plant growth. These findings have led to an innovative spin-off in LED lighting for horticulture and vertical farming, delivering faster growth cycles, lover energy and resource costs, and superior crop yields.

Verified activity

Signals from Quant Bio Res A/S

1 published signal

Find the companies already in motion.

Customize signals around your market, buyers, competitors, and investment thesis.

© 2026 SeedOpsCompany intelligence.

SeedOps.

Quant Bio Res A/S Company Signals | SeedOps